Deloitte CIS and Genome Ventures develop Artificial Intelligence solutions has been added to your bookmarks.
Deloitte CIS and Genome Ventures develop Artificial Intelligence solutions
Moscow, 1 June 2017–Deloitte CIS and Genome Ventures have announced the launch of a joint initiative for the application of Artificial Intelligence (AI) to crucial social, business and management challenges.
The goal of the Deloitte CIS and Genome Ventures initiative is to establish new and more efficient ways of collaboration between businesses, science and technology, unveil the value AI can deliver for business and society, launch the first real world applications and increase the impact that outstanding Russian AI talents have.
The initiative will focus on a new form of leadership, which defines fast and flexible co-creation with leading public and private sector institutions. This will form the basis for a digital transformation grounded in hands-on experience in the digital world and will be the foundation for a new and open ecosystem.
Over the coming months experts from Deloitte CIS and Genome Ventures will engage with public and private stakeholders to define the key challenges to be addressed and will execute and implement the concept.
Genome Ventures is a venture-building company with the main focus on developing human capital, EdTech and Smart City Technologies. Genome Ventures has a solid portfolio of companies in eHealth and Talent identification services for Russian, CIS and global markets.
“We are excited to explore the opportunity to collaborate with Genome Ventures and are confident that our combined expertise will allow us to deploy AI to address business and social challenges such as how leverage data in the management of private and public institutions, to optimise the value we get from resources, and how to identify and improve Talent in a digital world. This will allow for efficiency, growth and game changing innovation,” stated Ian Colebourne, CEO, Deloitte CIS.
“We share the vision on the global market for the development of the AI landscape. Deloitte has unique expertise on the Russian market and a high potential team for creating AI solutions, while our entrepreneurial approach allows us to identify real business needs and deliver products and services generating value for different clients. Today, we set up this partnership to unveil the great talent we have in Russia and to create groundbreaking and world-famous AI solutions for efficient decision making,” stated Alexander Smbatyan, CEO, Genome Ventures.
With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and deep local expertise to help clients succeed wherever they operate.
Deloitte’s more than 244,400 professionals are committed to becoming the standard of excellence.
Deloitte CIS is a premier international professional services firm that offers audit, consulting, corporate finance, enterprise risk, and tax and legal services, leveraging professional experience of approximately 3,400 employees in 19 offices across 11 countries of the region.
Today, Deloitte has offices in Moscow, St. Petersburg, Ufa, Yekaterinburg, Yuzhno-Sakhalinsk and Novosibirsk (Russia), Kiev (Ukraine), Minsk (Belarus), Tbilisi (Georgia), Baku (Azerbaijan), Aktau, Almaty, Astana, Atyrau (Kazakhstan), Bishkek (Kyrgyzstan), Tashkent (Uzbekistan), Ashgabat (Turkmenistan), Dushanbe (Tajikistan) and Yerevan (Armenia).